XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Discontinued Operations
9 Months Ended
Sep. 30, 2021
Discontinued Operations And Disposal Groups [Abstract]  
Discontinued Operations

3.

Discontinued Operations

On October 18, 2020, we entered into a Stock Purchase Agreement (“Purchase Agreement”) with Kainos NS Holdings LP (“Parent”) and KNS Acquisition Corp., an indirect wholly owned subsidiary of Parent (“Purchaser,” and collectively with Parent, “Kainos”) to sell to Kainos all of the issued and outstanding capital stock of Nutrisystem, a wholly owned subsidiary of the Company.

Effective as of December 9, 2020, we completed the sale of Nutrisystem to Kainos for an aggregate purchase price, after giving effect to customary indebtedness and cash adjustments, of approximately $558.9 million, which amount was subject to a customary working capital adjustment post-closing.  Such working capital adjustment was finalized in the second quarter of 2021 and resulted in additional proceeds of $2.7 million. Additionally, we incurred $11.2 million of transaction costs in 2020 directly related to the disposition of Nutrisystem, resulting in net proceeds, after post-closing adjustment, of $550.4 million.  

 

In accordance with ASC Topic 205, “Presentation of Financial Statements”, the Nutrition business met the criteria for discontinued operations, as it was a component of the Company and the sale represented a strategic shift in the Company’s operations and financial results. Accordingly, the results of operations of the Nutrition business have been classified as discontinued operations for 2020 and 2021.

 

The following table presents financial results of the Nutrition business included in “loss from discontinued operations" for the three and nine months ended September 30, 2021 and 2020.

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(In thousands)

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Revenues

 

$

 

 

$

159,428

 

 

$

 

 

$

518,066

 

Cost of revenues

 

 

 

 

 

75,213

 

 

 

 

 

 

243,658

 

Marketing expenses

 

 

 

 

 

43,574

 

 

 

 

 

 

173,687

 

Selling, general and administrative expenses (1)

 

 

1,252

 

 

 

17,034

 

 

 

2,797

 

 

 

47,558

 

Depreciation and amortization

 

 

 

 

 

10,653

 

 

 

 

 

 

33,895

 

Impairment loss

 

 

 

 

 

66,198

 

 

 

 

 

 

265,698

 

Restructuring and related charges

 

 

 

 

 

30

 

 

 

 

 

 

472

 

Interest expense (2)

 

 

 

 

 

10,137

 

 

 

 

 

 

30,512

 

Pretax loss from discontinued operations

 

 

(1,252

)

 

 

(63,411

)

 

 

(2,797

)

 

 

(277,414

)

Loss on sale of Nutrition business (3)

 

 

 

 

 

 

 

 

(96

)

 

 

 

Total pretax loss from discontinued operations

 

 

(1,252

)

 

 

(63,411

)

 

 

(2,893

)

 

 

(277,414

)

Income tax benefit

 

 

(320

)

 

 

(4,243

)

 

 

(739

)

 

 

(23,174

)

Loss from discontinued operations, net

   of income tax benefit

 

$

(932

)

 

$

(59,168

)

 

$

(2,154

)

 

$

(254,240

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

For the three and nine months ended September 30, 2021, expenses from discontinued operations primarily relate to legal and other professional fees and separation costs.

 

 

(2)

The term loans under our Prior Credit Agreement (as defined in Note 8) originated with the purchase of Nutrisystem on March 8, 2019. Following the disposition of Nutrisystem, we repaid $519.0 million of principal on the term loans under the terms of our prior credit agreement. For the three and nine months ended September 30, 2020, we allocated interest expense to discontinued operations based on the interest expense incurred during such periods related to $519.0 million of term loan debt, using our historical interest rates. 

 

 

(3)

Represents additional loss recognized in the second quarter of 2021 upon final settlement of the post-closing working capital adjustment, as described above.

The depreciation, amortization and significant operating and investing non-cash items of the discontinued operations were as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(In thousands)

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Impairment of goodwill and intangible assets

 

$

 

 

$

66,198

 

 

$

 

 

$

265,698

 

Depreciation and amortization

 

 

 

 

 

10,653

 

 

 

 

 

 

33,895

 

Capital expenditures on discontinued operations

 

 

 

 

 

1,803

 

 

 

 

 

 

5,617

 

Deferred income taxes (benefits)

 

 

(320

)

 

 

(6,346

)

 

 

(739

)

 

 

(30,702

)

Share-based compensation on discontinued operations

 

 

 

 

 

926

 

 

 

 

 

 

1,673